Measuring compounds in exhaled air to detect Alzheimer's disease and Parkinson's disease

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Bach, Jan Philipp ^a   Gold, Maike ^b   Mengel, David ^b   Hattesohl, Akira ^b   Lubbe, Dirk ^c   Schmid, Severin ^b   Tackenberg, Björn ^b   Rieke, Jürgen ^b   Maddula, Sasidhar ^d   Baumbach, Jörg Ingo ^d   Nell, Christoph ^b   Boeselt, Tobias ^b   Michelis, Joan ^e   Alferink, Judith ^e,f   Heneka, Michael ^e,g   Oertel, Wolfgang ^b   Jessen, Frank ^e,g   Janciauskiene, Sabina ^h   Vogelmeier, Claus ^b   Dodel, Richard ^b   Koczulla, Andreas Rembert ^b   Blum, David ⁱ   more..

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d REUTLINGEN UNIVERSITY   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^h LEIBNIZ UNIVERSITY HANNOVER   (Germany)

ⁱ JEAN PIERRE AUBERT RESEARCH CENTER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CHEMICAL COMPOUND; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ELECTRONIC NOSE DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPIRED AIR; FEMALE; HUMAN; ION MOBILITY SPECTROMETRY; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PARKINSON DISEASE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; ANIMAL; BREATH ANALYSIS; C3H MOUSE; C57BL MOUSE; CASE CONTROL STUDY; CHEMISTRY; LUNG; MALE; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; SPECTROSCOPY; TRANSGENIC MOUSE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOMARKERS; BLOTTING, WESTERN; BREATH TESTS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; PARKINSON DISEASE; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS;

EID: 84940570044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132227     Document Type: Article

References (25)

1. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and bloodvessels. The EMBO journal. 1985; 4(11):2757-63. PMID: 4065091.
2. Cummings JL. Alzheimer's disease. N EnglJ Med. 2004; 351(1):56-67. PMID: 15229308.
3. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMID: 21514250. doi: 10.1016/j.jalz.2011.03.005
4. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012; 8 (1 Suppl):S1-68. Epub 2011/11/04. doi: 10.1016/j.jalz.2011.09.172 PMID: 22047634; PubMed Central PMCID: PMC3329969.
5. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734-46. Epub 2007/07/10. doi: 10.1016/s1474-4422(07)70178-3 PMID: 17616482.
6. Hoglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, et al. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides. Neurodegener Dis. 2008; 5(5):268-76. PMID: 18309230. doi: 10.1159/000119457
7. Holtzman DM. CSF biomarkers for Alzheimer's disease: current utility and potential future use. Neurobiol Aging. 2011; 32 Suppl 1:S4-9. Epub 2011/12/07. doi: 10.1016/j.neurobiolaging.2011.09.003 PMID: 22078172; PubMed Central PMCID: PMC3233690.
8. de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Annals of the New York Academy of Sciences. 2007; 1097:114-45. Epub 2007/04/07. doi: 10.1196/annals.1379.012 PMID: 17413016.
9. Dragonieri S, Annema JT, Schot R, van der Schee MP, Spanevello A, Carratu P, et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung cancer (Amsterdam, Netherlands). 2009; 64(2):166-70. Epub 2008/10/07. doi: 10.1016/j.lungcan.2008.08.008 PMID: 18834643.
10. Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. British journal of cancer. 2010; 103(4):542-51. Epub 2010/07/22. doi: 10.1038/sj.bjc.6605810 PMID: 20648015; PubMed Central PMCID: PMC2939793.
11. Lewis NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Accounts of chemical research. 2004; 37(9):663-72. Epub 2004/09/24. doi: 10.1021/ar030120m PMID: 15379582.
12. Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nature nanotechnology. 2009; 4(10):669-73. Epub 2009/10/08. doi: 10.1038/nnano.2009.235 PMID: 19809459.
13. Thaler ER, Hanson CW. Medical applications of electronic nose technology. Expert review of medical devices. 2005; 2(5):559-66. Epub 2005/11/19. doi: 10.1586/17434440.2.5.559 PMID: 16293067.
14. Peng G, Tisch U, Haick H. Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: toward diagnosis of diseases via breath samples. Nano letters. 2009; 9 (4):1362-8. Epub 2009/03/27. doi: 10.1021/nl8030218 PMID: 19320442.
15. Baumbach JI. Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. Journal of breath research. 2009; 3(3):034001. Epub 2009/09/01. doi: 10.1088/1752-7155/3/3/034001 PMID: 21383463.
16. Tisch U, Schlesinger I, Ionescu R, Nassar M, Axelrod N, Robertman D, et al. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors. Nanomedicine (London, England). 2013; 8(1):43-56. Epub 2012/10/17. doi: 10.2217/nnm.12.105 PMID: 23067372.
17. Barth S, Schonknecht P, Pantel J, Schroder J. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery]. Fortschritte der Neurologie-Psychiatrie. 2005; 73 (10):568-76. Epub 2005/10/12. doi: 10.1055/s-2004-830249 PMID: 16217697.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4. Epub 1992/03/01. PMID: 1564476; PubMed Central PMCID: PMCPmc1014720.
19. Hattesohl AD, Jorres RA, Dressel H, Schmid S, Vogelmeier C, Greulich T, et al. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose. Respirology (Carlton, Vic). 2011; 16(8):1258-64. Epub 2011/09/03. doi: 10.1111/j.1440-1843.2011.02047.x PMID: 21883674.
20. Huttmann EM, Greulich T, Hattesohl A, Schmid S, Noeske S, Herr C, et al. Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PloS one. 2011; 6(11):e27467. Epub 2011/11/17. doi: 10.1371/journal.pone.0027467 PMID: 22087323; PubMed Central PMCID: PMC3210176.
21. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax. 2009; 64(9):744-8. Epub 2009/01/23. doi: 10.1136/thx.2008.099465 PMID: 19158121.
22. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. American journal of respiratory and critical care medicine. 2009; 180(11):1076-82. Epub 2009/08/29. doi: 10.1164/rccm.200906-0939OC PMID: 19713445.
23. Wiltfang J, Lewczuk P, Riederer P, Grunblatt E, Hock C, Scheltens P, et al. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry. 2005; 6(2):69-84. Epub 2005/09/15. PMID: 16156480.
24. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, et al. Update on the biomarkercore of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010; 6(3):230-8. Epub 2010/05/11. doi: 10.1016/j.jalz.2010.03.008 PMID: 20451871; PubMed Central PMCID: PMC2867838.
25. Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, et al. Solvent exposures and Parkinson disease risk in twins. Ann Neurol. 2012;71(6):776-84. Epub 2011/11/16. doi: 10.1002/ana.22629 PMID: 22083847; PubMed Central PMCID: PMC3366287.